JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

Jakafi oral (ruxolitinib) - Novartis, Incyte

fludarabine - generics

Revimmune (cyclophosphamide high dose) - Accentia

mycophenolate mofetil - generics

melphalan - generics

busulfan - generics

cyclophosphamide oral - generics

methotrexate - generics

http://clinicaltrials.gov/ct2/show/NCT02251821

Apr 20, 2019